Your browser doesn't support javascript.
loading
Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.
Rahimli, Tural; Hidayetov, Tural; Yusifli, Zerife; Memmedzade, Hidayet; Rajabov, Tural; Aghayev, Kamran.
Affiliation
  • Rahimli T; Department of Neurosurgery, Baku Medical Plaza, Baku, Azerbaijan. Electronic address: dr.rehimli@hotmail.com.
  • Hidayetov T; Department of Neurosurgery, Baku Medical Plaza, Baku, Azerbaijan.
  • Yusifli Z; Department of Pathology, Central Custom Hospital, Baku, Azerbaijan.
  • Memmedzade H; Department of Endocrinology, Baku Medical Plaza, Baku, Azerbaijan.
  • Rajabov T; Department of Neurosurgery, Baku Medical Plaza, Baku, Azerbaijan.
  • Aghayev K; Department of Neurosurgery, Biruni University, Istanbul, Turkey.
World Neurosurg ; 149: e1043-e1055, 2021 05.
Article in En | MEDLINE | ID: mdl-33524611
ABSTRACT

OBJECTIVE:

To present the outcomes of endoscopic endonasal surgery for giant pituitary adenomas and discuss the extent of resection to minimize morbidity and mortality.

METHODS:

We retrospectively reviewed medical records of 44 patients with giant pituitary adenomas who underwent endoscopic endonasal surgery. Clinical presentation, laboratory results, imaging studies, clinical outcomes, extent of resection, and complications were collected and analyzed. Factors affecting long-term outcome according to surgical technique were identified and analyzed.

RESULTS:

Radical resection (RR) was defined as either gross total resection or near-total resection (90%-100% of the tumor). There were 28 patients (63.6%) who underwent RR, 10 patients (22.7%) who underwent subtotal resection, and 6 patients (13.6%) who underwent partial resection. Visual improvement was achieved in 27 patients (81.8%). Thirteen patients (72.2%) with pituitary dysfunction had improvement in at least 1 preoperative endocrinological dysfunction. RR rates for dumbbell and multilobular tumors were 44.4% and 28.6%, respectively. Surgical complications were observed in 14 (31.8%) patients. Major vascular injury occurred in 3 patients (6.8%). Mean follow-up period was 38.5 months (range, 1-70 months). No patients with RR had recurrence or residual tumor progression. Ten patients (22.7%) received adjuvant radiation therapy after resection. Two patients were reoperated on for tumor regrowth, and 3 patients (including the 2 patients with tumor regrowth) were lost to follow-up.

CONCLUSIONS:

Long-term follow-up results and low recurrence rate of tumors indicate that RR is effective to decrease morbidity and mortality.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma / Neuroendoscopy / Natural Orifice Endoscopic Surgery Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma / Neuroendoscopy / Natural Orifice Endoscopic Surgery Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Year: 2021 Type: Article